The effect of short-term fasting, apolipoprotein E gene polymorphism, and sex on plasma lipids

American Journal of Clinical Nutrition

Volumn 66, Issue 3, 1997, Pages 599-605

  Lehtimäki, Terho ^a   Frankberg Lakkala, Helena ^b   Solakivi, Tiina ^b   Koivisto, Anna Maija ^b   Laippala, Pekka ^b   Ehnholm, Christian ^b   Jokela, Hannu ^b   Koivula, Timo ^b   Nikkari, Tapio ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

Apolipoprotein E phenotype; HDL cholesterol; High density lipoprotein cholesterol; LDL cholesterol; Low density lipoprotein cholesterol; Sex; Sex differences; Short term fasting; Triacylglycerols; Triglycerides

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; CHOLESTEROL METABOLISM; CORONARY ARTERY DISEASE; DIET RESTRICTION; DNA POLYMORPHISM; FAT INTAKE; FEMALE; GENETIC VARIABILITY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; SEX DIFFERENCE; SHORT TERM MEMORY;

EID: 1842410758     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/66.3.599     Document Type: Article

References (51)

1. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987;113:433-9.
2. Davignon JR, Gregg E, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
3. Hixon JE. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb 1991;11:1237-44.
4. Stengård JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995;91:265-9.
5. Brown MS, Herz J, Kowal RC, Goldstein JL. The low-density lipoprotein receptor-related protein: double agent or decoy? Curr Opin Lipidol 1991;2:65-72.
6. Zannis VI, Just PW, Breslow JL. Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet 1981;33:11-24.
7. Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 1977;269:604-7.
8. Huttunen JK, Ehnholm C, Nikkilä EA, Ohta M. Effect of fasting on two postheparin plasma triglyceride lipases and triglyceride removal in obese subjects. Eur J Clin Invest 1975;5:435-45.
9. Taskinen M-R, Nikkilä EA. Effects of caloric restriction on lipid metabolism in man. Changes of tissue lipoprotein lipase activities and of serum lipoproteins. Atherosclerosis 1979;32:289-99.
10. Hietanen E, Laitinen M, Ahonen E, Marniemi J, Nousiainen U. Changes in serum lipids and lecithin: cholesterol acyltransferase enzyme during 1 week weight reduction of women on a low-calorie diet. Enzyme 1983;29:160-6.
11. Marniemi J, Vuori I, Kinnunen V, Rahkila P, Vainikka M, Peltonen P. Metabolic changes induced by combined prolonged exercise and lowcalorie intake in man. Eur J Appl Physiol 1984;53:121-7.
12. Ellis RW, Darga LL, Lucas CP. The short-and long-term effect of a low-fat, cholesterol-free, hypocaloric diet on serum triglyceride and cholesterol distribution in severely obese humans. Int J Obes 1987;11:29-40.
13. Wadden TA, Stunkard AJ, Brownell KD. Very low calorie diets: their efficacy, safety, and future. Ann Intern Med 1983;99:675-84.
14. Felig P. Editorial retrospective. Very-low-calorie protein diets. N Engl J Med 1984;310:589-91.
15. Wood PD, Stefanick ML, Dreon DM, et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 1988;319:1173-9.
16. Atkinson RL. Low and very low calorie diets. Med Clin North Am 1989;73:203-15.
17. Doherty JU, Wadden TA, Zuk L, Letizia KA, Foster GD, Day SC. Long-term evaluation of cardiac function in obese patients treated with a very-low-calorie diet: a controlled clinical study of patients without underlying cardiac disease. Am J Clin Nutr 1991;53:854-85.
18. Anderson JW, Hamilton CC, Brinkman-Kaplan V. Benefits and risks of an intensive very-low-calorie diet program for severe obesity. Am J Gastroenterol 1992;87:6-15.
19. Shoji T, Nishizawa Y, Koyama H, et al. High-density-lipoprotein metabolism during a very-low-calorie diet. Am J Clin Nutr 1992;56(suppl):297S-8S.
20. Yamamoto R, Inoue S, Saito M, Okamoto M, Okamura A, Takamura Y. Very-low-calorie-diet therapy in severe obesity. Am J Clin Nutr 1992;56(suppl):299S-302S.
21. Parenti MA, Babini C, Cecchetto ME, et al. Lipid, lipoprotein, and apolipoprotein assessement during an 8-wk very-low-calorie diet. Am J Clin Nutr 1992;56(suppl):268S-70S.
22. Foster GD, Wadden TA, Peterson FJ, Letizia KA, Bartlett SJ, Conill AM. A controlled comparison of three very-low-calorie diets: effects on weight, body composition, and symptoms. Am J Clin Nutr 1992;55:811-7.
23. Hainer V, Kunešová M, Štich V, et al. Body-fat distribution and serum lipids during the long-term follow-up of obese patients treated initially with a very-low-calorie diet. Am J Clin Nutr 1992;56(suppl):283S-5S.
24. Mänttäri M, Koskinen P, Ehnholm C, Huttunen JK, Manninen V. Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 1991;40:217-21.
25. 4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 1990;10:285-8.
26. Miettinen TA, Gylling H, Vanhanen H. Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet 1988;2:1261.
27. Boerwinkle E, Brown SA, Rohrbach K, Gotto AM Jr, Patsch W. Role of apolipoprotein-E and apolipoprotein-B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet 1991;49:1145-54.
28. Savolainen JM, Rantala M, Kervinen K, et al. Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype. Atherosclerosis 1991;86:145-52.
29. Cobb MM, Teitlebaum H, Risch N, Jekel J, Ostfeld A. Influence of dietary fat, apolipoprotein E phenotype, and sex on plasma lipoprotein levels. Circulation 1992;86:849-57.
30. de Knijff P, Boomsma DI, de Wit E, et al. The effect of the apolipoprotein E phenotype on plasma lipids is not influenced by environmental variability: results of a Dutch twin study. Hum Genet 1993;91:268-72.
31. Glatz JF, Pierre N, Demacker M, Turner PR, Katan MB. Response of serum cholesterol to dietary cholesterol in relation to apolipoprotein E phenotype. Nutr Metab Cardiovasc Dis 1991;1:13-7.
32. Mentzel HJ, Utermann G. Apolipoprotein E phenotyping from serum by Western blotting. Electrophoresis 1986;7:492-5.
33. Lehtimäki T, Moilanen T, Viikari J, et al. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 1990;31:487-95.
34. Allen JK, Hensley WJ, Nicholls AV, Whitfield JB. An enzymic and centrifugal method for estimating high density lipoprotein cholesterol. Clin Chem 1979;25:325-7.
35. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
36. Carlson LA, Fröberg SO. Blood lipid and glucose levels during a ten day period of low-calorie intake and exercise in man. Metabolism 1967;16:624-34.
37. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992;56:320-8.
38. Streja DA, Marliss EB, Steiner G. The effect of prolonged fasting on plasma triglyceride kinetics in man. Metabolism 1977;26:505-16.
39. Kesäniemi YA, Beltz WF, Grundy SM. Comparison of clofibrate and caloric restriction on kinetics of very low density lipoprotein triglycerides. Arteriosclerosis 1985;5:151-3.
40. Ehnholm C, Mahley RW, Chappell DA, Weisgraber KH, Ludwig E, Witztum JL. Role of apolipoprotein E in the lipolytic conversion of β-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc Natl Acad Sci U S A 1984;81:5566-70.
41. Kesäniemi YA, Färkkilä M, Kervinen K, Koivisto P, Vuoristo M, Miettinen TA. Regulation of low-density lipoprotein apolipoprotein B levels. Am Heart J 1987;113:508-13.
42. Demant T, Bedrod D, Packard CJ, Shepherd J. Apolipoprotein E polymorphism and apolipoprotein B metabolism in vivo. Circulation 1989;80(suppl):277(abstr).
43. Demant T, Bedrod D, Packard CJ, Shepherd J. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects. J Clin Invest 1991;88:1490-501.
44. Warnick GR. Lipoprotein(a) is included in low-density lipoprotein by NCEP definition. Clin Chem 1994;40:2115-6.
45. Kesäniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987;80:578-81.
46. Gylling H, Miettinen TA. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. J Lipid Res 1992;33:1361-71.
47. Miettinen TA, Gylling H, Vanhanen H, Ollus A. Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler Thromb 1992;12:1044-452.
48. Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987;80:1571-7.
49. Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brever HB. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 1986;78:815-25.
50. Breninkmeijer BJ, Stuyt PMJ, Demacker PNM, Scalenhoef AFH, van't Laar A. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype. J Lipid Res 1987;28:361-70.
51. Lehtimäki T, Moilanen T, Porkka K, et al. Association between serum lipids and apolipoprotein E phenotype is influenced by diet in a population-based sample of free-living children and young adults: the Cardiovascular Risk in Young Finns Study. J Lipid Res 1995;36:653-61.